vTv Therapeutics (VTVT) Competitors $15.46 -0.97 (-5.90%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VTVT vs. ENOB, LUMO, CMPX, OPT, HRTX, INZY, CRBU, TNYA, NBTX, and KYTXShould you be buying vTv Therapeutics stock or one of its competitors? The main competitors of vTv Therapeutics include Enochian Biosciences (ENOB), Lumos Pharma (LUMO), Compass Therapeutics (CMPX), Opthea (OPT), Heron Therapeutics (HRTX), Inozyme Pharma (INZY), Caribou Biosciences (CRBU), Tenaya Therapeutics (TNYA), Nanobiotix (NBTX), and Kyverna Therapeutics (KYTX). These companies are all part of the "medical" sector. vTv Therapeutics vs. Enochian Biosciences Lumos Pharma Compass Therapeutics Opthea Heron Therapeutics Inozyme Pharma Caribou Biosciences Tenaya Therapeutics Nanobiotix Kyverna Therapeutics Enochian Biosciences (NASDAQ:ENOB) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership. Does the MarketBeat Community believe in ENOB or VTVT? vTv Therapeutics received 351 more outperform votes than Enochian Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformEnochian BiosciencesN/AN/AvTv TherapeuticsOutperform Votes35157.73% Underperform Votes25742.27% Does the media refer more to ENOB or VTVT? In the previous week, Enochian Biosciences and Enochian Biosciences both had 1 articles in the media. vTv Therapeutics' average media sentiment score of 0.36 beat Enochian Biosciences' score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enochian Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral vTv Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, ENOB or VTVT? Enochian Biosciences has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500. Is ENOB or VTVT more profitable? Enochian Biosciences' return on equity of -154.69% beat vTv Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Enochian BiosciencesN/A -154.69% -130.66% vTv Therapeutics N/A -184.64%-47.29% Do insiders & institutionals believe in ENOB or VTVT? 7.2% of Enochian Biosciences shares are owned by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are owned by institutional investors. 21.7% of Enochian Biosciences shares are owned by company insiders. Comparatively, 1.3% of vTv Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has preferable earnings & valuation, ENOB or VTVT? vTv Therapeutics has higher revenue and earnings than Enochian Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnochian BiosciencesN/AN/A-$113.43MN/AN/AvTv Therapeutics$2.02M23.04-$20.25M-$4.53-3.41 SummaryvTv Therapeutics beats Enochian Biosciences on 6 of the 9 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTVT vs. The Competition Export to ExcelMetricvTv TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$49.46M$6.48B$5.07B$8.89BDividend YieldN/A8.11%4.99%4.07%P/E Ratio-3.414.4283.5712.93Price / Sales23.04375.031,220.3088.33Price / CashN/A52.5939.4636.25Price / Book2.6010.126.936.25Net Income-$20.25M$153.61M$119.12M$225.93M7 Day Performance-1.16%-2.00%-1.83%-1.32%1 Month Performance10.43%-7.47%-3.64%0.60%1 Year Performance48.94%31.80%31.64%26.23% vTv Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTVTvTv Therapeutics0.3329 of 5 stars$15.46-5.9%N/A+10.4%$49.46M$2.02M-3.419ENOBEnochian BiosciencesN/AN/AN/AN/A$40.80MN/A0.0022Gap UpLUMOLumos Pharma3.2102 of 5 stars$4.32-0.2%$8.63+99.7%+41.2%$37.45M$2.05M0.0030CMPXCompass Therapeutics3.4294 of 5 stars$1.37-3.5%$6.75+392.7%-18.9%$195.38MN/A0.0020OPTOpthea2.074 of 5 stars$3.31+1.5%$12.00+262.5%+72.4%$190.37M$120,000.000.008HRTXHeron Therapeutics3.9688 of 5 stars$1.12-5.9%$5.67+406.0%-13.8%$180.99M$127.04M0.00300Analyst DowngradeShort Interest ↓INZYInozyme Pharma1.2302 of 5 stars$2.79-0.7%$15.71+463.2%-28.5%$180.51MN/A0.0050CRBUCaribou Biosciences2.9283 of 5 stars$1.96-1.5%$11.25+474.0%-64.7%$180.20M$34.48M0.00100TNYATenaya Therapeutics3.9666 of 5 stars$2.22-2.2%$14.75+564.4%+18.4%$179.83MN/A0.00110Gap UpNBTXNanobiotix2.3432 of 5 stars$4.07+7.7%$11.50+182.7%-33.5%$178.16M$39.18M0.00100Positive NewsKYTXKyverna Therapeutics2.8357 of 5 stars$4.12+1.0%$25.71+524.1%N/A$176.14M$7.03M0.0096Analyst ForecastAnalyst RevisionGap Up Related Companies and Tools Related Companies ENOB Alternatives LUMO Alternatives CMPX Alternatives OPT Alternatives HRTX Alternatives INZY Alternatives CRBU Alternatives TNYA Alternatives NBTX Alternatives KYTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VTVT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
